Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank21
3Y CAGR-12.7%
5Y CAGR-9.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-12.7%/yr
vs -0.8%/yr prior
5Y CAGR
-9.7%/yr
Consistent
Acceleration
-11.9pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $57.48M | +3.3% |
| 2024 | $55.63M | -19.1% |
| 2023 | $68.74M | -20.4% |
| 2022 | $86.33M | -8.5% |
| 2021 | $94.39M | -1.5% |
| 2020 | $95.82M | -39.1% |
| 2019 | $157.46M | +76.8% |
| 2018 | $89.04M | -33.2% |
| 2017 | $133.26M | +27.8% |
| 2016 | $104.26M | - |